Bersiporocin for idiopathic pulmonary fibrosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 May 2022: Trial registered, NCT05389215
  2. 29 Jul 2022: Trial started, NCT05389215

The trials

NCT05389215: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

State
Under way
Phase
Phase 2
People
102 planned
Started
29 Jul 2022
Primary completion
13 Oct 2026
Arms
DWN12088 Xmg Tablet (BID)
Results
None posted
  1. 25 May 2022: Trial registered
  2. 29 Jul 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.